Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic rearrangements in primary liver cancers: cause and consequences
Letizia Satriano, Monika Lewińska, Pedro M. Rodrigues, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 12, pp. 748-766
Closed Access | Times Cited: 196

Showing 1-25 of 196 citing articles:

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1685
The immunological and metabolic landscape in primary and metastatic liver cancer
Xin Li, Pierluigi Ramadori, Dominik Pfister, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 9, pp. 541-557
Closed Access | Times Cited: 389
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du, Chan Liu, Mengyao Qin, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 558-580
Open Access | Times Cited: 351
Lipid alterations in chronic liver disease and liver cancer
Bichitra Paul, Monika Lewińska, Jesper B. Andersen
JHEP Reports (2022) Vol. 4, Iss. 6, pp. 100479-100479
Open Access | Times Cited: 189
Arginine reprograms metabolism in liver cancer via RBM39
Dirk Mossmann, Christoph Müller, Sujin Park, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5068-5083.e23
Open Access | Times Cited: 104
Metabolic reprogramming in cholangiocarcinoma
Chiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 849-864
Open Access | Times Cited: 97
Comparing DESI-MSI and MALDI-MSI Mediated Spatial Metabolomics and Their Applications in Cancer Studies
Michelle He, Wenjun Pu, Xi Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 72
PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma
Kui Wang, Li Luo, Shuyue Fu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
Metabolic reprogramming and its clinical implication for liver cancer
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 56
Deep whole-genome analysis of 494 hepatocellular carcinomas
Lei Chen, Chong Zhang, Ruidong Xue, et al.
Nature (2024) Vol. 627, Iss. 8004, pp. 586-593
Closed Access | Times Cited: 38
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer
Fuming Li, Pingyu Liu, Mi Wen, et al.
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 131-146
Open Access | Times Cited: 25
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 17
The current knowledge concerning solid cancer and therapy
Masoud Najafi, Jamal Majidpoor, Heidar Toolee, et al.
Journal of Biochemical and Molecular Toxicology (2021) Vol. 35, Iss. 11
Closed Access | Times Cited: 89
Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation
Xiang Jin, Chang Chen, Rui Liu, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 8
Open Access | Times Cited: 81
Therapeutic efficacy of FASN inhibition in preclinical models of HCC
Haichuan Wang, Yi Zhou, Hongwei Xu, et al.
Hepatology (2022) Vol. 76, Iss. 4, pp. 951-966
Open Access | Times Cited: 64
Lipid metabolism in pancreatic cancer: emerging roles and potential targets
Xinpeng Yin, Ruiyuan Xu, Jianlu Song, et al.
Cancer Communications (2022) Vol. 42, Iss. 12, pp. 1234-1256
Open Access | Times Cited: 61
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
Monika Lewińska, Álvaro Santos‐Laso, Enara Arretxe, et al.
EBioMedicine (2021) Vol. 73, pp. 103661-103661
Open Access | Times Cited: 57
Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma
Fangzhou Liu, Tian Tian, Zhen Zhang, et al.
Nature Metabolism (2022) Vol. 4, Iss. 8, pp. 1022-1040
Closed Access | Times Cited: 54
Ferroptosis and its interaction with tumor immune microenvironment in liver cancer
Yilan Huang, Siwei Wang, Ai‐Wu Ke, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188848-188848
Closed Access | Times Cited: 47
CRISPR/Cas9 Screens Reveal that Hexokinase 2 Enhances Cancer Stemness and Tumorigenicity by Activating the ACSL4‐Fatty Acid β‐Oxidation Pathway
Hongquan Li, Junjiao Song, Yifei He, et al.
Advanced Science (2022) Vol. 9, Iss. 21
Open Access | Times Cited: 46
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export
Xiaopeng Yu, Huanjun Tong, Jialu Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 33
Multi-stimuli-responsive molecular fluorescent probes for bioapplications
Shan-Shan Xue, Yuanyuan Li, Wei Pan, et al.
Chemical Communications (2023) Vol. 59, Iss. 21, pp. 3040-3049
Closed Access | Times Cited: 24
PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
Qi Zhou, Leijia Li, Feifei Sha, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2372-2386
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top